Nvax upgrades. Find the latest Novavax, Inc. ’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Citi upgraded Novavax (NASDAQ: NVAX) from Neutral to Buy with a price target of $3. May 12, 2025 · Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. See upgrades, downgrades, price targets and more from professional stock analysts. Includes annual, quarterly and trailing numbers with history and charts. Novavax sha May 10, 2024 · Novavax (NVAX) stock is taking off on Friday, reaching a new 52-week high. stock news by MarketWatch. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Jun 13, 2025 · Novavax, Inc. 00) on shares of Novavax in a report on Thursday, October Jan 25, 2025 · Analyst Upgrades and Downgrades Several research firms recently issued reports on NVAX. Oct 16, 2024 · Novavax shares plummet 30% as FDA places clinical hold on COVID-19 and influenza combination vaccine due to serious adverse event. The analyst double upgrades the name ahead of Q1 2019 pivotal data from the PREPARE In depth view into Novavax Return on Equity including historical data from 1995, charts and stats. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the first participants have been dosed in its COVID-19-Influenza Aug 26, 2025 · In depth view into Novavax Dividend Yield including historical data from 1995, charts and stats. 1 strain. Stay updated on expert opinions and forecasts for NVAX stock. Where is Novavax stock heading? Wall Street analysts weigh in with their latest ratings and NVAX price targets at PriceTargets. The news also saw JPMorgan upgrade NVAX shares today. 22, 2025 at 1:37 p. Analysts and investors Aug 28, 2025 · In a recent update, HC Wainwright & Co. Get real-time Novavax Inc (NVAX) stock price, news, financials, community insights, and trading ideas. Looking Oct 2, 2024 · Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting with management. Aug 5, 2024 · On Novavax's (NVAX) second-quarter earnings call, investors will likely focus on the company's pipeline updates and collaboration revenue numbers from its recently entered deal with Sanofi. Jun 30, 2025 · In depth view into Novavax Stock Buybacks (Quarterly) including historical data from 1995, charts and stats. 98, Novavax has been one of the more dramatic rides in the biotech world, and lately, headlines have seemed to throw fuel onto an already volatile fire. With a recent close at $7. CFRA upgraded Novavax (NASDAQ: NVAX) from Hold to Buy with a price target of $71. In depth view into Novavax Short Interest including historical data from 1995, charts and stats. Mar 4, 2021 · Shareholders in Novavax, Inc. Sep 1, 2024 · Introduction Novavax's (NASDAQ: NVAX) stock is up almost 40% since my rating upgrade to "hold" in May. May 10, 2024 · Novavax's partnership with Sanofi provides stability and a shift of strategy, improving their outlook in the fierce vaccine market. 00 price target on shares of Novavax in a […] May 21, 2025 · Indeed, NVAX still has plenty of risk that investors need to consider, however, the FDA approval unlocks several bullish stimuli that create an asymmetric setup in the near-term and long-term. 00 to $25. 4%, and profit growth estimate of 64. In depth view into Novavax 50-Day Simple Moving Average including historical data from 1995, charts and stats. (NVAX), including rating factors, key financial indicators and corporate details. The stock has been a wild ride for risk-tolerant investors and cautious traders alike. Dec 10, 2024 · Novavax, Inc. 00 price target on Track NVAX Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Dec 31, 2020 · Detailed annual and quarterly income statement for Novavax (VIE:NVAX). See Novavax, Inc. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. Novavax Inc 주가(NVAX)와 차트, 최신 뉴스, 내부자 거래, 재무 분석 데이터를 확인하여 신중한 투자 결정을 위한 정보를 살펴보세요. Feb 28, 2025 · Why Novavax, Inc. May 18, 2025 · Novavax (NVAX) stock in focus as the U. 94% expected returns from stock's previous close. Get live stock quotes and historical data for Novavax (NVAX). Complete Novavax Inc. Jan 13, 2025 · Novavax shares are trading lower by 9. In depth view into Novavax Return on Invested Capital (Annual) including historical data from 1995, charts and stats. May 11, 2024 · B of A Securities Upgrades Novavax (NVAX)Fintel reports that on May 10, 2024, B of A Securities upgraded their outlook for Novavax (NasdaqGS:NVAX) from Underperform to Neutral. 71. 04 to a high of $39. The prospect is a major setback for In depth view into Novavax 30-Day Average Daily Volume including historical data from 1995, charts and stats. 2 billion with Sanofi for its COVID-19 vaccine in exchange for a stake that valued the U. Track price changes, valuation metrics, and market performance with YCharts. Jefferies said Novavax was ramping up Covid Jun 6, 2024 · Novavax (NVAX) stock zipped higher Thursday — and then gave it all up — after the Food and Drug Administration set a potential approval date for its Covid vaccine in April. 35 million. 4 days ago · Stock forecasts and analyst price target predictions for Novavax, Inc. Apr 11, 2025 · The decline in Novavax stock follows the HHS Secretary's concerns regarding the efficacy of its protein-based COVID-19 vaccine in a recent interview. In depth view into Novavax Dividend including historical data from 1995, charts and stats. Novavax (NVAX) Stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for NVAX in the last 3 months. In depth view into Novavax Institutional Investor Ownership Percentage including historical data from 1995, charts and stats. Jan 2, 2025 · Analyst Upgrades and Downgrades NVAX has been the subject of several research analyst reports. 57%. Jul 23, 2024 · Novavax's (NVAX) shares continue to soar thanks to the recently signed partnership with Sanofi (SNY) to market its COVID-19 vaccine and develop novel COVID-19-influenza combination vaccines. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U. Elsewhere, the Dow saw an upswing of 0. May 10, 2024 · Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1. Dec 31, 2020 · Detailed balance sheet for Novavax (VIE:NVAX), including cash, debt, assets, liabilities, and book value. 64%. 89% Upside As of May 8, 2024, the average one-year price target for Novavax is 15. Click here to read an analysis of NVAX stock now. Read more here. View real-time NVAX stock price and news, along with industry-best analysis. Anyone Novavax (NASDAQ:NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting with management. Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. has upgraded its rating for Novavax (NVAX, Financial) to a "Buy" with a new price target set at $10. Learn why top analysts are making this stock forecast for Novavax at MarketBeat. 50 (from $2. Click here to find out why NVAX stock is a Hold. ’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background. Jun 30, 2025 · Overview of Novavax, Inc. Riley reissued a "buy" rating and issued a $26. The forecasts range from a low of 4. NVAX updated stock price target summary. (NVAX) stock, with detailed revenue and earnings estimates. Aug 28, 2025 · In a recent update, HC Wainwright & Co. Jul 30, 2024 · Novavax (NVAX) stock fell as J. HC Wainwright initiated coverage on Novavax in a research note on Thursday, August 28th. 90. Riley reiterated a "buy" rating and issued a $26. ET on GuruFocus. The vaccine maker's stock has dropped by 10. NVAX stock quote prices, financial information, real-time forecasts, and company news from CNN. 33%. Analyst Price Forecast Suggests 76. 5 days ago · Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr. m. Aug 20, 2025 · BofA downgraded Novavax (NVAX) to Underperform from Neutral with a price target of $7, down from $9, citing the recent share movement and "increasingly murky outlook" for Novavax's key drivers. Jul 11, 2025 · Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. May 10, 2024 · Novavax on Friday said it had struck a licensing deal worth at least $1. Jefferies Financial Group cut their price target on Novavax from $31. Other equities research analysts also recently issued research reports about the company. 16, 2025 7:53 AM ET Novavax, Inc. This compares to the stock's 28. Read my update on NVAX stock. 1% loss on the day. 1 day ago · Analyst Upgrades and Downgrades A number of research firms recently issued reports on NVAX. May 19, 2025 · Shares of Novavax NVAX surged nearly 26% in pre-market trading today after its protein-based COVID-19 vaccine, Nuvaxovid, received the long-awaited approval from the FDA, albeit with a narrower label than initially expected. 00 USD. Feb 27, 2025 · On Thursday, Novavax Inc (NASDAQ:NVAX) reported fourth-quarter 2024 sales of $88. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Apr 28, 2025 · Novavax shows financial improvement but faces vaccine challenges. (NVAX) stock. Click here to find out why NVAX is a Buy. View the latest Novavax Inc. Despite regulatory and competitive risks. May 30, 2024 · Novavax, Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NVAX stock price. 99% at $8. Dec 31, 2020 · Financial ratios and valuation metrics for Novavax (NVAX). The Zacks Consensus JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine NVAX - The Fly JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine JPMorgan NVAX May 11, 2024 · Fintel reports that on May 10, 2024, B of A Securities upgraded their outlook for Novavax (NasdaqGS:NVAX) from Underperform to Neutral. Sep 8, 2025 · Discover real-time Novavax, Inc. Jan 16, 2025 · Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade) Jan. In depth view into Novavax Return on Equity including historical data from 1995, charts and stats. Oct 3, 2024 · Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the previous session. See why NVAX maintains a "Hold" rating. 00 price objective on shares of Novavax in a report on Tuesday, December 10th. 00 price objective for the company. Oct 3, 2023 · The Food and Drug Administration on Tuesday authorized an updated version of Novavax's Covid vaccine, allowing doses to begin shipping to doctors' offices and pharmacies across the country. Just Novavax Inc. 42K Follower s Play (9min) Explore Novavax analyst ratings and price targets (NASDAQ:NVAX) on Benzinga. Citigroup initiated coverage on Novavax in a research report on Tuesday, June 17th. 4 days ago · Should You Buy or Sell Novavax Stock? Get The Latest NVAX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. analyst ratings, historical stock prices, earnings estimates & actuals. Dec 31, 2024 · Current and historical number of employees for Novavax (NVAX) with related statistics, a chart and a data table. May 9, 2025 · Novavax, Inc. 00). Mar 1, 2025 · Novavax (NASDAQ:NVAX – Get Free Report) was upgraded by analysts at TD Cowen to a “hold” rating in a research report issued on Thursday,Zacks. (NVAX) stock, including real-time price, chart, key statistics, news, and more. (NVAX) stock, including valuation metrics, financial numbers, share information and more. analyst estimates, including NVAX earnings per share estimates and analyst recommendations. See Novavax, Inc. 39. 4 days ago · Novavax, Inc. (NVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Consensus estimates suggest investors could Apr 11, 2025 · Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Stay ahead with Nasdaq. Morgan and Bank of America to upgrade the company. 0%. FDA. 08% in the past month, falling short of the Medical sector's gain of 0. (NASDAQ:NVAX) had a terrible week, as shares crashed 23% to US$184 in the week since its latest annual results. Listing of latest press releases and statements by Novavax. 5 days ago · Current and historical analyst ratings for Novavax (NVAX) stock. Mar 29, 2018 · (Updated - March 29, 2018 7:29 AM EDT)(updated to add analyst comment)Seaport Global Securities upgraded Novavax (NASDAQ: NVAX) from Neutral to Buy with a price target of Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health. Morgan downgraded the company to underweight, citing overvaluation amid recent rally due to Sanofi (SNY) partnership. Goldman Dec 31, 2020 · Financial ratios and metrics for Novavax (VIE:NVAX). Novavax Inc (NVAX) Stock Price, Chart, Latest News, Technical Indicator, Option Chain and much more. Get Novavax news, earnings, and stock analysis — all in one place at TipRanks. NVAX - Novavax, Inc - Stock screener for investors and traders, financial visualizations. Find Novavax Inc (NVAX) news, corporate events, press releases, latest company updates and headlines Jun 30, 2025 · In depth view into Novavax Debt to Equity Ratio including historical data from 1995, charts and stats. The analyst comments "On the back of the announced licensing deal with Sanofi, we are upgrading Sep 24, 2014 · SolarCity Corporation (SCTY) – The firm's stock was 'Conviction Buy' rated with a $96 price target at Goldman Sachs (GS) implying 58. May 10, 2024 · NVAX stock is rising higher after the biotechnology company announced that it had signed a licensing deal with Sanofi. 57%, while the tech-heavy Nasdaq depreciated by 0. Sep 2, 2024 · The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country. Find the latest analyst research, reports, and ratings for Novavax, Inc. May 10, 2024 · Novavax (NVAX) stock reaches a 52-week high as a licensing deal with Sanofi (SNY) prompts J. The decrease was due to lower Feb 2, 2025 · Analyst Upgrades and Downgrades NVAX has been the subject of several recent analyst reports. (NVAX) stock discussion in Yahoo Finance's forum. 53. Zscaler (ZS) was upgraded to Outperform from Neutral by BNP Paribas. Finally, Jefferies May 10, 2024 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax (NASDAQ: NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit a new 52-week high after A high-level overview of Novavax, Inc. 00 target price (up from $23. Apr 25, 2025 · The U. has a share price target of US$ 16, revenue growth forecast of -26. - NVAX - stock price prediction, stock price target, analyst ratings from 6 analysts Novavax, Inc. (NVAX) Before we jump into Novavax, Inc. Apr 28, 2025 · Novavax (NVAX) is in focus after the company responded to the FDA's call for an additional clinical trial for its COVID-19 vaccine. In the last week, shares are up 1. 4 days ago · NVAX's current price target is $14. Mar 31, 2025 · In depth view into Novavax Net Income (Quarterly) including historical data from 1995, charts and stats. 24. Sep 16, 2025 · NVAX | Complete Novavax Inc. In depth view into Novavax Total Employees (Annual) including historical data from 1995, charts and stats. Novavax, Inc. Common Stock (NVAX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. This marks a significant change, bringing a fresh perspective to the shares of Novavax as the company receives optimistic outlooks amidst its recent market activities. View Novavax, Inc. 2. ’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background. B. P. They set a “buy” rating and a $10. This change lagged the S&P 500's 0. FDA’s Conditions on NVAX’s COVID-19 Jab While the agency granted full approval to Nuvaxovid for use in older adults aged 65 and above, it restricted the vaccine’s Apr 23, 2025 · Novavax (NVAX) shares surge 23% as FDA seeks additional data for COVID-19 vaccine approval. 4 days ago · In depth view into Novavax Enterprise Value including historical data from 1995, charts and stats. (NVAX) range from a low of $6 to a high of $25. Analyst Joel Beatty is more positive on the company noting he views the Phase Jul 31, 2025 · In depth view into Novavax Shares Outstanding including historical data from 1995, charts and stats. The average price target represents a increase of $46. Read why I rated NVAX stock as 'Hold' and what risks and opportunities await investors. 2% for FY24, based on top 6 analyst calls. However, zooming out, the story gets trickier. Jul 30, 2024 · Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns. (NVAX) Stock NVAX 8 Comments Out of Ignorance 7. Sep 14, 2025 · Trying to figure out what to do with Novavax stock? You are not alone. May 8, 2025 · Novavax (NVAX) stock jumps 35% as the company raises its 2025 revenue outlook and its Q1 2025 financials surpasses forecasts significantly. 7%, and year-to-date Novavax Inc. . This comes on the back of a deal with Sanofi (SNY). (NVAX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. May 9, 2025 · Why Novavax, Inc. Jun 30, 2025 · In depth view into Novavax Profit Margin (Quarterly) including historical data from 1995, charts and stats. 's CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' In depth view into Novavax Cash and Equivalents (Annual) including historical data from 1995, charts and stats. S. 00) on shares of Novavax in a report on Thursday, October 10th. Nov 12, 2024 · Novavax (NVAX) stock falls 12% in premarket as company cuts full-year revenue guidance due to a lower sales outlook for its COVID-19 vaccine Nuvaxovid. In depth view into Novavax Cash (Per Share Quarterly) including historical data from 1995, charts and stats. JPMorgan analyst Eric Joseph upgraded Novavax (NASDAQ: NVAX) from Underweight to Overweight. Novavax beat revenue forecasts by a solid 19%, hitting Feb 19, 2025 · Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. 00 (from $57. 8% loss over the past four weeks. 8% during Monday's session. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine before it will consider approving it. Novavax is a biotech company advancing health through R&D and partnerships. stock information by Barron's. Research Novavax's (Nasdaq:NVAX) fundamentals, past performance, valuation, dividends and more. 6 days ago · In the latest close session, Novavax (NVAX) was down 1. Jun 14, 2024 · About Novavax Novavax, Inc. HC Wainwright reiterated a "buy" rating and issued a $19. Over the last month, Novavax is down 16. Jun 27, 2025 · Novavax Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare In depth view into Novavax Revenue (Annual) including historical data from 1995, charts and stats. ’s stock price changed recently Upgrades and downgrades for NVAX from analysts NVAX’s stock price momentum as measured by its relative strength About Novavax, Inc. In the last reported quarter, the company’s earnings beat estimates by 12. 86% and the S&P 500's gain of 2. 29. com. biotech firm at double its Find the latest Novavax, Inc. They set a “sell” rating and a $6. The Find the latest Novavax, Inc. HC Wainwright reissued a “buy” rating and set a $19. 00 and set a "buy" rating for the company in a report on Wednesday, October 16th. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. The upgrade followed a collaboration with Sanofi (SNY), granting the pharma giant a license 3 days ago · A detailed overview of Novavax, Inc. Share your opinion and gain insight from other stock traders and investors. View (NVAX) real-time stock price, chart, news, analysis, analyst reviews and more. Detailed statistics for Novavax, Inc. 75). 4 days ago · The forecasts for Novavax, Inc. com reports. The average price target represents an May 8, 2024 · Fintel reports that on May 10, 2024, B of A Securities upgraded their outlook for Novavax (NasdaqGS:NVAX) from Underperform to Neutral. Click for my NVAX stock update. Common Stock (NVAX) at Nasdaq. 4 billion with Sanofi (SNY, FR:SAN). com Aug 30, 2024 · Novavax shares surge as FDA grants emergency use authorization for updated COVID-19 vaccine targeting Omicron variant JN. Looking Apr 23, 2025 · Novavax stock jumps on positive FDA discussionsShould you invest $2,000 in NVAX right now? With NVAX making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of Sep 16, 2025 · Novavax (NVAX) Price Target Lowered by B of A Securities | NVAX Stock News Jul. Novavax (NVAX) upgraded to Neutral from Underweight at JPMorgan with analyst Eric Joseph saying the stock's 995% rally year-to-date reflects the potential promise for the company's COVID-19 vaccine program, NVX-CoV2373, having recently initiated phase 1 testing. Apr 7, 2025 · Novavax NVAX shares soared 11. May 10, 2024 · JPMorgan analyst Eric Joseph upgraded Novavax (NASDAQ: NVAX) from Underweight to Neutral. May 19, 2025 · Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from the U. 31 million, compared to $291 million a year, beating the consensus of $84. View real-time stock prices and stock quotes for a full financial overview. Today, Novavax (NASDAQ:NVAX) stock received an upgrade by Citigroup from Neutral to Buy. In depth view into Novavax Cash Dividend Payout Ratio including historical data from 1995, charts and stats. See many years of revenue, expenses and profits or losses. (NASDAQ:NVAX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. 00 target price on shares of Novavax in a report on Tuesday, December 10th. 4% in the last trading session to close at $6. The move was backed by solid volume with far more shares changing hands than in a normal session. This new rating was announced by analyst Sean Lee on August 28, 2025. Shares of vaccine stocks are trading lower after Moderna issued 2025 revenue guidance below analyst estimates. 54 from the last closing price of $8. Sep 15, 2025 · If you are wondering whether it is time to buy, hold, or finally let go of Novavax, you are not alone. bslqy wkgq gbkguerp nnwii xcnzmdu zvfvf udqvxb ksmko hlbyv fvnpo